Dosing regimens for neural stem cell proliferating agents and differentiating agents for the treatment of neurological disorders
View Patent ↗Effective dosing regimens for neural stem cell proliferating and differentiating agents, kits comprising effective dosing regimens for neural stem cell proliferating and differentiating agents, and uses thereof are provided herein. Such kits and methods can be utilized acutely or chronically to treat a neurodegenerative disease or condition. Furthermore, the compositions and methods can be used continuously or intermittently in various dosing regimens.
1. A method of treating or ameliorating a neurodegenerative disease or condition in a mammal comprising administering to the mammal an effective amount of human chorionic gonadotropin (hCG) during a first treatment period lasting at least three days and administering to the mammal an effective amount of erythropoietin (EPO) during a second treatment period lasting at least three days, wherein the neurodegenerative disease or condition is a stroke, and wherein the second treatment period starts after the end of the first treatment period.
2. The method of claim 1 , wherein the hCG is administered systemically.